newsfilter
← Latest News
Business Wire·

Verastem Oncology Announces Proposed Public Offering of Common Stock

Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell shares of its common